| May 7 ,2008 |
Mycamine® Has Now Been Approved in Europe
(PDF 94KB) |
| May 7 ,2008 |
Astellas Receives an Approvable Letter for an Immunosuppressant FK506 Modified Release Formulation in the U.S.
(PDF 46KB) |
| April 25 ,2008 |
Astellas and CoMentis Sign Agreement to Collaborate on the Research, Development
and Commercialization of Beta-Secretase Inhibitors
(PDF 32KB) |
| April 24 ,2008 |
Change of Representative Directors
(PDF 31KB) |
| April 11 ,2008 |
CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM)
(regadenoson) Injection
(PDF 23KB) |
| April 2 ,2008 |
The FDA Accepts the Complete Response for Clinical Holds of FG-2216*/FG-4592 for the Treatment of Anemia
(PDF 34KB) |
| April 1 ,2008 |
IR website renewed.
|
| March 14 ,2008 |
Astellas Receives an Approvable Letter for Their Immunosuppressant FK506 Modified Release Formulation in the U.S. (PDF 48KB) |
| March 10 ,2008 |
Conclusion of Co-Development and Co-Marketing Agreement on a Functional Dyspepsia Agent Z-338/YM443 in Japan with Zeria
(PDF 28KB) |
| March 10 ,2008 |
The abstract of the result of Phase IIa study in EU for the beta 3 adrenoceptor agonist YM178 is available on the website of the 23rd European Association of Urology (EAU) annual congress held during March 26 to 29, 2008.
|
| March 5 ,2008 |
Astellas Reaches Settlement Agreement with Taiyo on the Oral Cephalosporin
Antibiotic Cefzon® Litigations
(PDF 30KB) |
| March 4 ,2008 |
Astellas Announces Global Management System and Establishes Global Development
Functional Headquarters
(PDF 53KB) |
| March 4 ,2008 |
Theravance, Inc. issued press release with regard to FDA cancellation of Advisory Committee meeting for the injectable antibiotic telavancin.
|
